440 related articles for article (PubMed ID: 9185762)
1. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
Viitala K; Israel Y; Blake JE; Niemelä O
Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
[TBL] [Abstract][Full Text] [Related]
3. IgA immune responses against acetaldehyde adducts and biomarkers of alcohol consumption in patients with IgA glomerulonephritis.
Kaartinen K; Niemelä O; Syrjänen J; Alatalo P; Pörsti I; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Alcohol Clin Exp Res; 2009 Jul; 33(7):1231-7. PubMed ID: 19389190
[TBL] [Abstract][Full Text] [Related]
4. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
6. Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease.
Latvala J; Hietala J; Koivisto H; Järvi K; Anttila P; Niemelä O
Am J Gastroenterol; 2005 Jun; 100(6):1303-10. PubMed ID: 15929761
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
8. Studies on the usefulness of acetaldehyde-modified proteins and associated antibodies as markers of alcohol abuse.
Worrall S; Jersey JD; Wilce PA; Seppa K; Sillanaukee P
Alcohol Alcohol Suppl; 1994; 2():503-7. PubMed ID: 8974375
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of C3b-binding in chronic liver diseases.
Hautanen A; Salaspuro MP
Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
[TBL] [Abstract][Full Text] [Related]
10. Conversion of acetaldehyde-protein adduct epitopes from a nonreduced to a reduced phenotype by antigen processing cells.
Klassen LW; Jones BL; Sorrell MF; Tuma DJ; Thiele GM
Alcohol Clin Exp Res; 1999 Apr; 23(4):657-63. PubMed ID: 10235301
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease.
Stewart SF; Vidali M; Day CP; Albano E; Jones DE
Hepatology; 2004 Jan; 39(1):197-203. PubMed ID: 14752838
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
Dreskin SC; Goldsmith PK; Gallin JI
J Clin Invest; 1985 Jan; 75(1):26-34. PubMed ID: 3871199
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to heat shock proteins in patients with pulmonary sarcoidosis.
Hrycaj P; Wurm K; Mennet P; Müller W
Sarcoidosis; 1995 Sep; 12(2):124-30. PubMed ID: 8532959
[TBL] [Abstract][Full Text] [Related]
14. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects.
Worrall S; De Jersey J; Shanley BC; Wilce PA
Alcohol Alcohol; 1990; 25(5):509-17. PubMed ID: 1708257
[TBL] [Abstract][Full Text] [Related]
16. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
[TBL] [Abstract][Full Text] [Related]
17. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
Yokoyama H
Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
[TBL] [Abstract][Full Text] [Related]
18. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis.
Holstege A; Bedossa P; Poynard T; Kollinger M; Chaput JC; Houglum K; Chojkier M
Hepatology; 1994 Feb; 19(2):367-74. PubMed ID: 7507463
[TBL] [Abstract][Full Text] [Related]
19. Antibodies made against a formaldehyde-protein adduct cross react with an acetaldehyde-protein adduct. Implications for the origin of antibodies in human serum which recognize acetaldehyde-protein adducts.
Pietrzak ER; Shanley BC; Kroon PA
Alcohol Alcohol; 1995 May; 30(3):373-8. PubMed ID: 7545992
[TBL] [Abstract][Full Text] [Related]
20. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]